首页> 外国专利> BENZOPHENONES AS INHIBITORS OF IL- AND TNF-, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD

BENZOPHENONES AS INHIBITORS OF IL- AND TNF-, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD

机译:苯甲酚类IL-和TNF-的抑制剂,药物组成和治疗方法

摘要

FIELD: organic chemistry, medicine, pharmacy.;SUBSTANCE: invention relates to new derivatives of benzophenone of the general formula (I): or their pharmaceutically acceptable salts and N-oxides, i. e. compounds wherein nitrogen atom at heterocyclic substitute can be oxidized. Compounds show property of inhibitor of interleukin (IL-1) or alpha-tumor necrosis factor (TNF-) and can be used in treatment of inflammatory diseases and states. In compound of the general formula (I) R1 represents (C1-C6)-alkyl; R2 represents one or some similar or different substitutes taken among the group consisting of hydrogen, halogen atom, (C1-C6)-alkyl, (C1-C6)-alkoxy-group; R3 represents one substitute at ortho-position taken among the group consisting of hydrogen, halogen atom; R4 represents hydrogen atom; R5 represents nitrogen-containing heteroaromatic mono- or bicyclic system comprising 1-4 heteroatoms taken among nitrogen (N), sulfur (S) or oxygen (O) atoms wherein each ring comprises 5 or 6 atoms in ring with exception for triazine being indicated mono- or bicyclic system is substituted optionally with hydrogen, halogen atom, halidealkyl, cyano-, carboxy-, nitro-group, (C1-C6)-alkyl, (C1-C6)-alkoxy-group, (C1-C6)-alkoxycarbonyl, -NR9R10 wherein R9 and R10 represent hydrogen atom; X represents oxygen atom. Also, invention relates to a pharmaceutical composition and to a method for treatment and prophylaxis of diseases.;EFFECT: improved treatment method, valuable medicinal properties of compounds.;20 cl, 3 tbl, 83 ex
机译:技术领域:本发明涉及通式(I)的二苯甲酮的新衍生物:<图像文件=“ 00000002.GIF” he =“ 48” imgContent =“ undefined” imgFormat =“ GIF “ wi =“ 95” />或其药学上可接受的盐和N-氧化物,即e。其中杂环取代基上的氮原子可被氧化的化合物。化合物具有白介素(IL-1)或α肿瘤坏死因子(TNF-)抑制剂的特性,可用于治疗炎症和状态。在通式(I)的化合物中,R 1 代表(C 1 -C 6 )-烷基; R 2 代表氢,卤素原子,(C 1 -C 6 )-中的一个或一些相似或不同的取代基-烷基,(C 1 -C 6 )-烷氧基; R 3 表示氢,卤素原子中的一个在邻位的取代基。 R 4 代表氢原子; R 5 表示含氮杂芳族单环或双环系统,其包含1-4个杂原子,所述杂原子选自氮(N),硫(S)或氧(O)原子,其中每个环均包含5个或6个原子表示三嗪的环,单环或双环系统可选地被氢,卤素原子,卤代烷基,氰基,羧基,硝基取代(C 1 -C 6 < / Sub>)-烷基,(C 1 -C 6 )-烷氧基,(C 1 -C 6 < / Sub>)-烷氧羰基,-NR 9 R 10 其中R 9 和R 10 代表氢原子; X代表氧原子。此外,本发明涉及药物组合物以及用于治疗和预防疾病的方法。效果:改进的治疗方法,化合物的有价值的医学特性; 20 cl,3 tbl,83 ex

著录项

  • 公开/公告号RU2270194C2

    专利类型

  • 公开/公告日2006-02-20

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20020134487

  • 发明设计人 KHORNEMAN ANNE MARI (DK);

    申请日2001-05-18

  • 分类号C07D213/74;C07D213/80;C07D215/38;C07D217/22;C07D235/30;C07D239/42;C07D241/26;C07D263/58;C07D277/82;C07D277/42;C07D473/34;C07D209/40;A61K31/44;A61K31/47;A61K31/404;A61K31/505;A61K31/52;A61K31/4965;A61K31/426;A61K31/421;A61K31/415;A61P29;

  • 国家 RU

  • 入库时间 2022-08-21 21:21:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号